curasan Enters Joint Venture to Research Biosurgical Therapies

Xlife Sciences and curasan have formed Novaxomx, a joint biosurgical company. The venture will focus on the research, development, certification, production and marketing of disruptive therapies for use in musculoskeletal disease treatment and tissue regeneration.

Novaxomx' primary goal is to optimize biomimetic osteoconductive carrier materials...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us